I considered CDXS briefly when it was discussed on this board around the time of the IPO in mid 2010 (e.g. #msg-50642602). I decided not to invest because CDXS struck me as a company without a clear plan to become profitable.
In mid 2011, Shell, who could easily have bought the whole company for what amounted to bus change, instead transferred its 16% equity stake in CDXS to a JV with Brazil’s Cosan (#msg-63841851).
CDXS’ pharma-API business is not a reason for owning the stock, IMO (#msg-63535620).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.